Urinary Tract Infection (UTI) in Pregnancy

Last updated: April 25, 2025

Urinary Tract Infection (UTI) in pregnancy

UTI in pregnancy is commonly caused by an ascending infection of the urinary tract from existing gastrointestinal and genitourinary tract flora. It is defined as the presence of ≥ 100,000 organisms/mL of urine if asymptomatic or > 100 organisms/ml of urine with pyuria (> 7 WBC/mL) in symptomatic women. The most common cause is Escherichia coli. Others include Klebsiella, Proteus, GBS etc. The risk of UTI increases in pregnancy mainly due urinary stasis (elevated progesterone relaxes the detrusor muscles and the gravid uterus makes it difficult to void), dehydration and **glycosuria. Ureteral dilatation and stasis commonly occurs on the right due to compression by a dexrorotated uterus. UTI is associated with adverse fetal risk and the biggest risk for development of symptomatic UTI is asymptomatic bacteriuria (carries a 20-30x increased risk; hence it is screened and treated during first ANC visit and third trimester visit).

Summary of UTI during pregnancy

Asymptomatic bacteriuriaAcute cystitisPyelonephritis
Urine culturePositivePositivePositive
Urgency, frequency, burningNoYesYes
FeverNoNoYes
CVA tendernessNoNoYes
  • Primary prevention of UTI in pregnancy
    • Avoid bathing. Shower instead
    • Wash hands before using toilet
    • Wipe front to back
    • Use liquid soap (less likely to have bacteria growing on it)
    • Clean urethral meatus area first

Urinary tract change in pregnancy

  • Renal pelvis and ureters
    • Progesterone reduces ureteral tone, peristalsis and contraction pressure → vesicoureteral reflux
    • The gravid uterus applies pressure on the bladder and compresses the ureters
    • Compression of ureters by enlarged vessels in the suspensory ligaments of the ovary
    • Relative immunosuppression
    • Right ureter is more affected than the left because it is affected by dextrorotation of the uterus by the sigmoid colon, as well as kinking as it crosses the right iliac artery
  • Bladder
    • Edematous and hyperemic mucosa
    • Progesterone induces bladder wall relaxation and increases the capacity
    • The enlarged uterus displaces the bladder superiorly, anteriorly and flattens it, which can decrease capacity
    • Increased incidence of microhematuria
  • Intermittent vesicoureteral reflux
    • Due to incompetence of the vesicoureteral valve from bladder flaccidity
    • Increased intravesical pressure
    • Decreased intraureteral pressure
  • Postpartum changes from trauma during labor and delivery
    • Mucosal congestion and submucosa haemorrhage
    • Decreased bladder sensitivity/ sensation
    • Detrusor atony
    • Postvoidal residual volume
    • Bladder overdistension
    • Urinary retention
  • Impaired tubular function
    • Reduced fractional reabsorption of glucose, amino acids, and beta microglobulin

Asymptomatic bacteriuria (ASB)

All women are screened for bacteriuria at their first ANC visit.

Approximately 10% of women have positive urinary culture. 30-50% with ASB will develop symptomatic UTI (Pyelonephritis) if not treated.

  • Risk factors
    • Lower socioeconomic status
    • Diabetes
    • History of urinary tract infection
    • Multiparity
    • Anatomic or functional urinary tract anomalies
    • Sickle cell trait
  • Signs and symptoms
    • None…it is asymptomatic
  • Physical exam
    • Unremarkable
  • Investigation
    • Urinalysis and urine culture
  • Treatment
    • Nitrofurantoin
    • Repeat culture after treatment and q1mos thereafter
    • Daily suppression treatment with nitrofurantoin or cephalexin if it persists after two courses

Acute cystitis

  • Symptoms
    • Burning urination
    • Sensation of incomplete voiding
    • Urinary urgency
    • Frequency
    • Suprapubic discomfort
  • Physical exam
    • Tenderness on pelvic exam with manipulation of bladder
  • Investigation
    • Urinalysis and urine culture
      • Positive nitrites
      • Positive esterase
      • Increased WBCs, RBCs
      • Proteinuria
      • +/- bacteria
      • Positive culture
  • Treatment
    • Nitrofurantoin 100mg BD 7-10 days
    • Repeat culture after treatment
    • Daily suppression treatment for women with two or more UTIs and for women with increased risk of UTIs e.g. diabetes, sickle cell trait

Pyelonephritis

Women with pyelonephritis are generally sick-looking

  • Signs and symptoms
    • Malaise
    • Fatigue
    • Chills
    • Anorexia
    • Fever
    • Symptoms of acute cystitis (burning urination, sensation of incomplete voiding, urinary urgency, frequency and suprapubic discomfort)
  • Physical exam
    • Sick-looking
    • Costovertebral angle (CVA) tenderness
    • Flank tenderness
  • Investigations
    • Urinalysis and culture
    • Blood culture
    • Complete Blood Count
    • Urea, Electrolytes and Creatinine
  • Treatment
    • Admit
    • IV antibiotics
      • 2nd or 3rd generation cephalosporin (ceftriaxone) or ampicillin + gentamicin
      • Transition to oral medications after afebrile for 24-48 hours (try not to give antipyretics to monitor fever)
      • Daily suppression therapy for remainder of pregnancy
    • Control nausea with doxylamine/B12 (if woman is dehydrated will put fetus at risk)
    • Judicious use of IV fluids (inflammatory response puts the patient at risk of ARDS)
  • Complications of pyelonephritis
    • Systemic Inflammatory Response Syndrome (SIRS)
    • Acute Respiratory Distress Syndrome (ARDS): pulmonary edema, injury
    • Renal dysfunction
    • Septic shock → hypoxic fetal events
    • Spontaneous abortion
    • Preterm delivery
    • Intrauterine Growth Restriction (IUGR) and Low Birth Weight (LBW) infant
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *